Literature DB >> 1787389

Human germ-line therapy: the case for its development and use.

B K Zimmerman1.   

Abstract

The rationale for pursuing the development and use of germ-line selection and modification techniques is examined in this essay. The argument is put forth that it is the moral obligation of the medical profession to make available to the public any technology that can cure or prevent pathology leading to death and disability, in both the present and future generations. Society should pursue the development of strategies for preventing or correcting, at the germ-line level, genetic features that will lead to, or enhance, pathological conditions. Because prenatal screening and even early embryo screening and selection can prevent only a subset of known genetic disorders, direct genetic intervention is the only way in which certain couples can exercise their rights to reproductive health. Finally, the arguments most often raised against the pursuit of and use of methods for germ-line intervention shall be discussed.

Entities:  

Keywords:  Analytical Approach; Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Year:  1991        PMID: 1787389     DOI: 10.1093/jmp/16.6.593

Source DB:  PubMed          Journal:  J Med Philos        ISSN: 0360-5310


  7 in total

1.  The ethics of germ line gene manipulation--a five dimensional debate.

Authors:  Lucy Carter
Journal:  Monash Bioeth Rev       Date:  2002-10

2.  Drawing the line on genetic intervention in humans.

Authors:  D R Kaura
Journal:  CMAJ       Date:  1996-03-15       Impact factor: 8.262

3.  Fostering a prevention mindset for responsible gene editing.

Authors:  Karen M Meagher; Zubin Master
Journal:  Account Res       Date:  2019-05-17       Impact factor: 2.622

Review 4.  Human gene therapy and the slippery slope argument.

Authors:  Veikko Launis
Journal:  Med Health Care Philos       Date:  2002

5.  Should we change the human genome?

Authors:  T Tännsjö
Journal:  Theor Med       Date:  1993-09

6.  Disease Resistance and the Definition of Genetic Enhancement.

Authors:  Derek So; Erika Kleiderman; Seydina B Touré; Yann Joly
Journal:  Front Genet       Date:  2017-04-10       Impact factor: 4.599

7.  Trust in Science: CRISPR-Cas9 and the Ban on Human Germline Editing.

Authors:  Stephan Guttinger
Journal:  Sci Eng Ethics       Date:  2017-06-26       Impact factor: 3.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.